By Michele Maatouk
Date: Monday 02 Jun 2025
(Sharecast News) - Sanofi said on Monday that it has agreed to buy US biopharmaceutical firm Blueprint Medicines for $9.1bn.
No recent information was found.
Currency | Euro |
Share Price | 82.26 |
Change Today | -1.40 |
% Change | -1.67 % |
52 Week High | 109.62 |
52 Week Low | 82.21 |
Volume | 1,509,733 |
Shares Issued | 1,256.00m |
Market Cap | 103,319m |
Beta | 0.72 |
Strong Buy | 13 |
Buy | 8 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
17:35 | 114 @ 82.26 |
17:35 | 150 @ 82.26 |
17:35 | 150 @ 82.26 |
17:35 | 150 @ 82.26 |
17:35 | 150 @ 82.26 |
You are here: research